Search Results for "Ansaid"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Ansaid. Results 1 to 3 of 3 total matches.
See also: flurbiprofen
Flurbiprofen
The Medical Letter on Drugs and Therapeutics • Apr 07, 1989 (Issue 789)
FOR
ONLINE USERS
FLURBIPROFEN
Flurbiprofen (Ansaid - Upjohn), a nonsteroidal anti-inflammatory drug (NSAID ...
Flurbiprofen (Ansaid - Upjohn), a nonsteroidal anti-inflammatory drug (NSAID) available in some countries since 1977, was recently approved by the US Food and Drug Administration for treatment of rheumatoid arthritis and osteoarthritis. Flurbiprofen is a fluorinated phenylalkanoic acid derivative structurally related to ibuprofen (Motrin;and others).
Oxaprozin for Arthritis
The Medical Letter on Drugs and Therapeutics • Feb 19, 1993 (Issue 890)
Flurbiprofen − Ansaid (Upjohn) 65.99
Ibuprofen
†
− average generic price (range: $4.77 to $20.74) 600 to 800 ...
Oxaprozin (Daypro -Searle), a propionic acid-derivative nonsteroidal anti-inflammatory drug (NSAID), has been approved by the US Food and Drug Administration for once-daily treatment of rheumatoid arthritis and osteoarthritis. Some of the NSAIDs previously marketed in the USA are listed in the table on page 16. Ibuprofen, naproxen, fenoprofen, ketoprofen, and flurbiprofen are also propionic acid derivatives. Piroxicam and nabumetone (Medical Letter, 34:38, 1992) are also approved for once-daily use, and indomethacin is available in an extended-release formulation that can be taken once...
Nabumetone - A New Nsaid
The Medical Letter on Drugs and Therapeutics • Apr 17, 1992 (Issue 868)
Flurbiprofen − Ansaid (Upjohn) 65.99
Ibuprofen
†
− average generic price (range: $4.77 to $20.74) 600 to 800 ...
Nabumetone (Relafen - SmithKline Beecham), a new nonsteroidal anti-inflammatory drug (NSAID), has been approved by the US Food and Drug Administration for treatment of rheumatoid arthritis and osteoarthritis. The drug has been available in the United Kingdom since 1987. The manufacturer claims that nabumetone is as effective as other NSAIDs and causes a relatively low incidence of peptic ulcers.